In addition to combining immune checkpoint inhibitors, it is also possible to construct CAR with anti-programmed cell death-Ligand 1 (PD-L1) scFv sequences (92), which are CAR-T cells that kill tumor cells while also blocking the PD-1/PD-L1 signaling pathway to release the immunosuppressive state. Here, CD274 is linked to neoplasm.